It's an interesting marketing move to give everyone a taste then move to API. I guess they're going to test the thesis if they can pull that kind of drug dealer trade off. They definitely piqued my interest to try to improve nostr.blue as much as possible in the two weeks but just can't tell from reviews if it's actually as good as they imply. The benchmarks sure do look nice though!